- Home
- VITL vs TVTX Comparison
VITL vs TVTX Comparison
Compare VITL & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- TVTX
- Stock Information
- Founded
- VITL 2007
- TVTX 2008
- Country
- VITL United States
- TVTX United States
- Employees
- VITL N/A
- TVTX N/A
- Industry
- VITL Packaged Foods
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- VITL Consumer Staples
- TVTX Health Care
- Exchange
- VITL Nasdaq
- TVTX Nasdaq
- Market Cap
- VITL 1.6B
- TVTX 1.4B
- IPO Year
- VITL 2020
- TVTX N/A
- Fundamental
- Price
- VITL $39.25
- TVTX $14.89
- Analyst Decision
- VITL Strong Buy
- TVTX Strong Buy
- Analyst Count
- VITL 8
- TVTX 16
- Target Price
- VITL $43.88
- TVTX $33.33
- AVG Volume (30 Days)
- VITL 828.7K
- TVTX 1.5M
- Earning Date
- VITL 08-07-2025
- TVTX 07-31-2025
- Dividend Yield
- VITL N/A
- TVTX N/A
- EPS Growth
- VITL 30.46
- TVTX N/A
- EPS
- VITL 1.13
- TVTX N/A
- Revenue
- VITL $620,567,000.00
- TVTX $273,533,000.00
- Revenue This Year
- VITL $25.26
- TVTX $73.84
- Revenue Next Year
- VITL $19.41
- TVTX $46.72
- P/E Ratio
- VITL $35.15
- TVTX N/A
- Revenue Growth
- VITL 23.96
- TVTX 75.65
- 52 Week Low
- VITL $27.91
- TVTX $7.72
- 52 Week High
- VITL $46.58
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- VITL 72.19
- TVTX 45.34
- Support Level
- VITL $35.30
- TVTX $14.36
- Resistance Level
- VITL $39.66
- TVTX $15.27
- Average True Range (ATR)
- VITL 1.57
- TVTX 0.61
- MACD
- VITL 0.53
- TVTX 0.15
- Stochastic Oscillator
- VITL 92.21
- TVTX 71.13
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.